PYXIS ONCOLOGY INC (PYXS) Stock Income Statement
NASDAQ:PYXS - Nasdaq - US7473241013 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.15M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 475.00K | N/A | N/A | N/A | N/A | |||
| Gross Profit | 15.67M | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 84.17M | 82.20M | 123.48M | 69.72M | 12.89M | |||
| Research and Development | 57.05M | 47.89M | 86.13M | 51.05M | 9.05M | |||
| Selling, General, and Administrative Expenses | 24.82M | 32.31M | 37.35M | 18.66M | 3.85M | |||
| Operating Income | -68.50M | -82.20M | -123.48M | -69.72M | -12.89M | |||
| Interest Income/Expense | 930.00K | 1.84M | 2.76M | -6.44M | 70.00K | |||
| Other Income/Expense | 9.04M | 6.56M | 0.00 | 180.00K | N/A | |||
| Non Recurring Items | -20.96M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -79.50M | -73.79M | -120.72M | -75.98M | -12.83M | |||
| Income Tax | -2.16M | N/A | N/A | N/A | N/A | |||
| Net Income | -77.33M | -73.79M | -120.72M | -75.98M | -12.83M | |||
| EBITDA | -65.51M | -80.27M | -122.77M | -69.07M | -12.42M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.32 | -1.85 | -3.65 | -2.36 | -0.39 | |||
| Non GAAP EPS | -0.95 | -1.85 | -3.62 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 97.06% | N/A | N/A | N/A | N/A | |||
| Profit Margin | -478.95% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -424.23% | N/A | N/A | N/A | N/A | |||
All data in USD